New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,United Kingdom ,Massachusetts ,Belgium ,Boston ,New Haven ,Connecticut ,Brussels ,Bruxelles Capitale ,Yale University ,Great Britain ,American ,Bruce Strober ,Emmanuel Caeymaex ,Eimear Obrien ,Antje Witte ,Immunology Solutions ,Brand Communications ,Twitter ,Drug Administration ,Central Connecticut Dermatology Research ,American Academy Of Dermatology ,European Union ,Corporate Communications ,Yale University School Of Medicine ,Department Of Dermatology ,Source Ucb Inc ,Annual Meeting ,Clinical Professor ,Yale University School ,Executive Vice President ,Euronext Brussels ,Coronavirus Pandemic ,Technology ,Business ,Health ,Psoriasis ,Pr Newswire ,Data Privacy ,Europe ,